health

AI-Powered Drug Discovery

Empowering scientists to design, make, and test new drugs to treat diseases

Pending AI develops AI and quantum mechanics-based capabilities to solve critical problem statements within the earliest stages of pharmaceutical research and development. The company trains AI models across massive federated datasets containing millions of data points to help scientists design, synthesize, and test new drugs more efficiently. Their platform dramatically improves the efficiency of the compound discovery pipeline.

Product

AI-Powered Molecular Design and Synthesis

Generative molecule designer and retrosynthesis engine that create novel molecular scaffolds and determine optimal synthesis routes for drug development.

Generative Molecule Designer

AI-powered de novo drug design that generates novel molecular scaffolds for further clinical development

Retrosynthesis Engine

AI-based synthesis planning that determines optimal routes to create target molecules

De Novo Drug Design

Generating entirely new molecular structures optimized for therapeutic targets

MillionsTraining Data
Top 100 InnovatorsRecognition
Google StartupsAccelerator

Contact Us

Learn More

Visit Pending AI